ABM Investama Tbk vs Prodia Diagnostic Line Tbk — how do they compare? ABM Investama Tbk trades at Rp2,650 (market cap 7.3T, 135K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: ABM Investama Tbk is far larger — about 15.5× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 135K). Which is the better fit depends on your goals.
| ABMM | PRDL | |
|---|---|---|
Market Cap | 7.3T | 470.58B |
Volume | 135K | 18.86M |
Lot | 1.35K | 188.57K |
Turnover | 358.21M | 4.97B |
Average Price | 2,653.39 | 263.63 |
Value | 358.21M | 4.97B |
Indicative Equilibrium Price | 2,650 | 264 |
Indicative Equilibrium Volume | 17 | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
ABM Investama, PT (the company) was established under its original name of PT Adiratna Bani Makmur on Jun 1, 2006 then changed to PT ABM Investama Tbk based on Notaries Deed dated Aug 31, 2009. The deed of establishment was approved by the the Ministry of Justice dated Oct 16, 2009. The Company’s articles of association has been amended several times, most recently by notarial deed No. 163 of Mrs. Aulia Taufani, S.H., dated Jul 21, 2011, concerning among others, public offering of stock.
Read more on ABMM →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →